Plessey shortlisted in 'Healthcare Technologies' category at IET awards

Plessey’s imPulse hand held device utilises Plessey’s patented EPIC sensing technology. Plessey’s EPIC disruptive technology has uses in the medical, automotive and industrial market segments. This sensor technology has been creating considerable interest within the medical community where the primary focus has been in using EPIC for surface body electrode physiology applications such as electrocardiograph, electromyograph, electroencephalograph, and electrooculography.

With Health and Wellbeing so prominent in people's minds, Plessey has developed in the imPulse sensor a simple to use hand held ECG monitor. Utilising Plessey's disruptive Electric Potential sensing technology to detect an ECG signal, all that is required is the simple placement of the thumbs on the sensors embedded in the imPulse unit. This allows for a routine, quick, accurate recording of a lead one ECG signal without the need for conductive gel or skin preparation. The signal is transmitted using Bluetooth to a Smartphone or Tablet computer and displays the ECG trace along with heart rate readout and provides a simple output indicating whether the user is at risk of AF (Arterial Fibrillation) a precursor to a stroke.

Alan Colman, EPIC Commercial Operations Director at Plessey, said: “We are delighted to be shortlisted in the Healthcare Technologies category at the IET awards. Plessey is dedicated to using the best of British research, manufacturing and engineering to create disruptive and innovative technologies to bring a positive influence to the interaction we all have with technology. Plessey’s imPulse capacitive lead one ECG sensing system is helping with the identification of Arterial Fibrillation in both primary and secondary care in the UK to be used as a screen for potential stroke victims.”

Winners of the IET awards will be announced at the award ceremony taking place on 16^th November at The Brewery, London.